Related Experiment Videos
Parkinsonism in Huntington's disease
1George-Huntington-Institute, Muenster, Germany; Department of Radiology, Universitaetsklinikum Muenster (UKM), Westfaelische Wilhelms-University, Muenster, Germany; Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
International Review of Neurobiology
|November 30, 2019
Summary
Huntington's disease (HD) motor symptoms evolve over time. Early Parkinsonian signs like bradykinesia appear years before chorea, challenging diagnosis in some patient groups.
Area of Science:
- Neurology
- Neurodegenerative Diseases
- Movement Disorders
Background:
- Huntington's disease (HD) is primarily known for chorea, involuntary hyperkinetic movements.
- Chorea's intensity peaks mid-stage and declines as HD progresses.
- Parkinsonian signs (bradykinesia, rigidity, postural instability) are often underestimated in HD.
Purpose of the Study:
- To highlight the progression and diagnostic challenges of Parkinsonian motor signs in Huntington's disease.
- To emphasize the early detection of bradykinesia using quantitative motor assessments.
Main Methods:
- Utilized quantitative motor (Q-Motor) assessments, including finger tapping (digitomotography).
- Analyzed motor symptom progression, comparing chorea and Parkinsonian signs over disease stages.
- Examined specific patient groups with atypical motor phenotypes.
Main Results:
- Bradykinesia is detectable in premanifest gene carriers up to two decades before clinical HD onset.
- Parkinsonian signs progress linearly and contribute to falls in advanced HD stages.
- A predominantly Parkinsonian motor phenotype, with minimal chorea, occurs in late-manifesting and pediatric HD patients, complicating early diagnosis.
Conclusions:
- The motor phenotype of Huntington's disease is more complex than just chorea.
- Early quantitative motor assessments can reveal Parkinsonian signs preceding overt HD symptoms.
- Diagnostic challenges exist for HD patients presenting with primarily Parkinsonian features, necessitating refined diagnostic criteria.
Related Concept Videos
Parkinson's Disease: Treatment
825
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
825
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Neural Regulation
42.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.8K
Lysosomal Hydrolases
4.3K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.3K